- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07608458
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
Scheduled Meditation for Perioperative Optimization: A Randomized Controlled Trial on Postoperative Outcomes, Pain, Anxiety, Insomnia, Stress, and Mobility in Pancreatectomy Patients
Studie Overzicht
Toestand
Gedetailleerde beschrijving
PRIMARY OBJECTIVES:
I. Evaluate the feasibility of implementing a meditation-based intervention in patients undergoing pancreatectomy, as measured by recruitment, retention, and participant compliance with the prescribed modules II. Evaluate the effect of a perioperative meditation intervention on anxiety, as measured by changes in State-Trait Anxiety Inventory (STAI) scores from baseline to one month postoperatively.
SECONDARY OBJECTIVE:
I. To observe the relationship of meditation intervention on change in health-related quality of life (HRQOL) outcomes for pain and sleep quality from baseline through one month postoperatively.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive access to the Headspace application. Patients complete mindfulness meditation including focused breathing, awareness of thought patterns, and management of mind-wandering for 10 minutes once daily (QD) for 3 weeks prior to surgery and twice daily (BID) for 1 month after surgery. Patients wear a Garmin activity tracker throughout the study.
ARM II: Patients receive access to the Headspace application at the time of hospital discharge and will be informed of the availability of the "Basics" meditation pack. Patients wear a Garmin activity tracker throughout the study.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
California
-
Duarte, California, Verenigde Staten, 91010
- City of Hope Medical Center
-
Contact:
- Bradford Kim
- Telefoonnummer: 626-218-1840
- E-mail: brakim@coh.org
-
Hoofdonderzoeker:
- Bradford Kim
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Documented informed consent of the participant and/or legally authorized representative
- Willing to install required apps on personal smartphone
- Willing to wear a Garmin wearable device throughout the study
- Age: ≥ 18 years
- Ability to read and understand English for questionnaires
- Owns a smartphone
- Comfortable with routine smartphone use
- Scheduled to undergo pancreatectomy
Exclusion Criteria:
- Participants with prior formal training in meditation or mindfulness (e.g., completion of structured courses, workshops, or certification programs)
- Participants who currently engage in a structured meditation or mindfulness practice, including regular use of mobile applications (e.g., Headspace, Calm, or similar platforms) or other formalized routines
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Arm I (Headspace meditation)
Patients receive access to the Headspace application.
Patients complete mindfulness meditation including focused breathing, awareness of thought patterns, and management of mind-wandering, for 10 minutes QD for 3 weeks prior to surgery and BID for 1 month after surgery.
Patients wear a Garmin activity tracker throughout the study.
|
Nevenstudies
Wear activity tracker
Complete mindfulness mediation
Andere namen:
Receive access to Headspace
Andere namen:
|
|
Experimenteel: Arm II (Delayed access to Headspace)
Patients receive access to the Headspace application at the time of hospital discharge and will be informed of the availability of the "Basics" meditation pack.
Patients wear a Garmin activity tracker throughout the study.
|
Nevenstudies
Wear activity tracker
Complete mindfulness mediation
Andere namen:
Receive access to Headspace
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Proportion of enrolled patients who complete the final study assessment (retention)
Tijdsspanne: Up to 6 months
|
Retention will be considered feasible if ≥ 70% of enrolled participants are retained.
Will be estimated along with the 95% exact binomial confidence interval.
|
Up to 6 months
|
|
Proportion of prescribed meditation modules completed (compliance)
Tijdsspanne: Up to 6 months
|
Each participant's proportion of completed meditation modules will be calculated using usage data from the Headspace mobile application.
Participants will then be classified as high (> 60%), medium (20-60%), or low (< 20%) compliance.
Will be estimated along with the 95% exact binomial confidence interval.
|
Up to 6 months
|
|
Change in patient-reported anxiety symptoms
Tijdsspanne: From baseline up to day 28
|
Measured using the State-Trait Anxiety Inventory (STAI).
Response is defined as a reduction of at least 6 points on STAI at date of surgery date relative to baseline.
The proportion of participants meeting this threshold will be reported.
Will be estimated along with the 95% exact binomial confidence interval.
Within-group mean change in STAI will be examined using paired t-tests (comparing any two time points of interest).
|
From baseline up to day 28
|
|
Proportion of invited patients who agree to participate (recruitment)
Tijdsspanne: Up to 6 months
|
Recruitment will be considered feasible if ≥ 50% of eligible patients enroll.
Will be estimated along with the 95% exact binomial confidence interval.
|
Up to 6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in patient-reported pain - Numeric Rating Scale
Tijdsspanne: rom the baseline assessment conducted three weeks prior to surgery through one month after surgery.
|
Change in patient-reported pain from baseline three weeks prior to surgery through one month postoperatively, measured using the Numeric Rating Scale (NRS, 0 -10 ).
0 means no pain to 10 means worst pain possible.
|
rom the baseline assessment conducted three weeks prior to surgery through one month after surgery.
|
|
Change in patient-reported pain - Brief Pain Inventory
Tijdsspanne: From the baseline assessment conducted three weeks prior to surgery up to one month after surgery.
|
Change in patient-reported pain from baseline three weeks prior to surgery through one month postoperatively, measured using the Brief Pain Inventory.(BPI).
0 means no pain to 10 means worst pain possible.
|
From the baseline assessment conducted three weeks prior to surgery up to one month after surgery.
|
|
Change in patient-reported Pittsburgh Sleep Quality Index (PSQI)
Tijdsspanne: From baseline up to one month after surgery.
|
Self-reported questionnaire will be used to measure sleep quality and sleep patterns over the past month.
PSQI will be interpreted by totaling the component scores into a global score ranging from 0 to 21, where higher scores indicate poorer sleep quality; a score greater than 5 generally suggests significant sleep disturbance or poor sleep quality.
|
From baseline up to one month after surgery.
|
|
Change in patient-reported Insomnia Severity Index (ISI)
Tijdsspanne: From baseline up to one month after surgery.
|
Self-reported questionnaire will be used to assess the severity and impact of insomnia symptoms, including difficulty falling asleep, staying asleep, and the effect of sleep problems on daily functioning.
The ISI is interpreted using a total score from 0 to 28: 0-7 indicates no clinically significant insomnia, 8-14 indicates subthreshold insomnia, 15-21 indicates moderate insomnia, and 22-28 indicates severe insomnia.
|
From baseline up to one month after surgery.
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Bradford Kim, City of Hope Medical Center
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Endocriene systeemziekten
- Neoplasmata per site
- Neoplasmata
- Neoplasmata per histologisch type
- Neoplasmata van het spijsverteringsstelsel
- Ziekten van het spijsverteringsstelsel
- Endocriene klierneoplasmata
- Alvleesklier Ziekten
- Ziekten van de galwegen
- Lever Ziekten
- Neoplasmata, glandulair en epitheel
- Adenocarcinoom
- Lever neoplasmata
- Carcinoom
- Neoplasmata van de galwegen
- Carcinoom, hepatocellulair
- Pancreasneoplasmata
- Onderzoekstechnieken
- Diagnostische technieken en procedures
- Diagnose
- Monitoring, fysiologisch
- Versnellingsbak
- Actigrafie
Andere studie-ID-nummers
- 25479 (Andere identificatie: City of Hope Medical Center)
- P30CA033572 (Subsidie/contract van de Amerikaanse NIH)
- NCI-2026-03206 (Register-ID: CTRP (Clinical Trial Reporting Program))
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .